Mycobacterium Infections, Nontuberculous: all 54 studies

Page 1 of 1. Open to participants first (19), then studies with results posted, then the rest; newest registration first within each.

• Hypertonic Saline Inhalation for Nontuberculous Mycobacterial Lung DiseaseRecruitingNCT07647575Not applicable
• A Study to Investigate Pharmacokinetics, Pharmacodynamics, and Safety of Subcutaneous Anifrolumab in Pediatric Participants 5 to < 18 Years of Age With Systemic Lupus ErythematosusRecruitingNCT07630714Phase 2
• To Evaluate the Clinical Efficacy and Safety of Omadacycline in the Treatment of Mycobacterium Abscessus Infection.Enrolling by invitationNCT07615309
• Testing a Novel Combination Treatment (Arm D) Versus Standard of Care for Intensive Phase Treatment for Mycobacterium Abscessus Pulmonary Disease in People With or Without Cystic Fibrosis in the Finding the Optimal Regimen for Mycobacterium Abscessus Treatment (FORMaT) Adaptive Platform TrialNot yet recruitingNCT07485010Phase 2
• Bacteriophage for Chronic Multidrug-Resistant Mycobacterium Abscessus Subsp. Abscessus Pulmonary InfectionNot yet recruitingNCT07429162Phase 1
• Clinical Study on the Early Bactericidal Activity of Contezolid Against Mycobacterium Abscessus DiseaseEnrolling by invitationNCT07372781Phase 2
• Environmental Reservoirs of Non-tuberculous Mycobacteria in Cystic Fibrosis HouseholdsRecruitingNCT07369414
• Epetraborole in Patients With Mycobacterium Abscessus Lung DiseaseRecruitingNCT07301320Phase 2
• Bacteriophage Therapy for Mycobacterium Abscessus Pulmonary InfectionEnrolling by invitationNCT07228702Phase 1
• Safety, Immunogenicity, and Efficacy of Therapeutic Mycobacterium Bovis BCG (BOOST)RecruitingNCT07094711Phase 2
• SARS-CoV-2 Specific Monoclonal Antibody for Post-COVID-19 Conditions (Long COVID)RecruitingNCT07021794Phase 2
• Clinical Study on the Early Bactericidal Activity of Sitafloxacin Against Mycobacterium Abscessus DiseaseEnrolling by invitationNCT06809413Phase 2
• M. Avium WGS During Mav-PD TreatmentRecruitingNCT06266442
• Mycobacteriophage Treatment of Non-tuberculosis MycobacteriaEnrolling by invitationNCT06262282
• Hypertonic Saline for MACRecruitingNCT04921943Phase 4
• Finding the Optimal Regimen for Mycobacterium Abscessus TreatmentRecruitingNCT04310930Phase 2/3
• IV Gallium Study for Patients With Cystic Fibrosis Who Have NTM (ABATE Study)RecruitingNCT04294043Phase 1
• Controls for Respiratory DiseasesRecruitingNCT03120481
• Study of Mycobacterial InfectionsRecruitingNCT00018044
• Oral Omadacycline vs. Placebo in Adults With NTM Pulmonary Disease Caused by Mycobacterium Abscessus Complex (MABc)CompletedNCT04922554Phase 2Results posted
• Validation of Patient Reported Outcome Measures in Participants With Nontuberculous Mycobacterial Lung Infection Caused by Mycobacterium Avium ComplexCompletedNCT04677543Phase 3Results posted
• A Proof of Concept Study of Inhaled Nitric Oxide for Adults With Pulmonary Non-Tuberculous Mycobacterial InfectionCompletedNCT03748992Phase 2Results posted
• Trial of Inhaled Molgramostim in Cystic Fibrosis Subjects With Nontuberculous Mycobacterial InfectionTerminatedNCT03597347Phase 2Results posted
• Pilot Trial of Inhaled Molgramostim in Non-tuberculous Mycobacterial (NTM) InfectionCompletedNCT03421743Phase 2Results posted
• Study to Evaluate Efficacy of LAI When Added to Multi-drug Regimen Compared to Multi-drug Regimen AloneCompletedNCT02344004Phase 3Results posted
• Safety and Tolerability Study of MEDI-551, a B-cell Depleting Agent, to Treat Relapsing Forms of Multiple SclerosisCompletedNCT01585766Phase 1Results posted
• Liposomal Amikacin for Inhalation (LAI) for Nontuberculous MycobacteriaCompletedNCT01315236Phase 2Results posted
• Special Investigation of Clarith/Klaricid in Patients With Non-tuberculous Mycobacterial Pulmonary InfectionsCompletedNCT01097005Results posted
• Study of Safety and Functional Imaging of cG250 and Sunitinib in Patients With Advanced Renal Cell CarcinomaTerminatedNCT00520533Phase 1Results posted
• ICoN-1 Phase 3 Study of the Efficacy and Safety of Treatment With MNKD-101, Clofazimine Inhalation SuspensionTerminatedNCT06418711Phase 3
• Study to Evaluate the Efficacy of Delpazolid as Add-on Therapy in Refractory Mycobacterium Abscessus ComplexCompletedNCT06004037Phase 2
• Treatment Outcome Between Mycobacterium Abscessus Infection in Chronic Lung Disease and Acquired Interferon-gamma Autoantibody SyndromeCompletedNCT05354583
• Multi-site Cohort Study for the Development of Personalized Pharmacotherapy in Patients With Tuberculosis (TB)Status unknownNCT05280886
• Study of a Nebulised Nitric Oxide Generating Solution in Patients With Mycobacterium AbscessusTerminatedNCT05101915Phase 2
• A Pilot Study to Assess the Effect of Intermittent iNO on the Treatment of NTM Lung Infection in CF and Non-CF PatientsCompletedNCT04685720Not applicable
• Study to Evaluate ALIS (Amikacin Liposome Inhalation Suspension) in Participants With Nontuberculous Mycobacterial Lung Infection Caused by Mycobacterium Avium ComplexCompletedNCT04677569Phase 3
• Recombinant Interleukin-7 (CYT107) to Treat Patients With Refractory Nontuberculous Mycobacterial Lung DiseaseTerminatedNCT04154826Phase 2
• Healthcare-associated Links in Transmission of Nontuberculous Mycobacteria in Cystic FibrosisCompletedNCT04024423
• Comparison of Two- Versus Three-antibiotic Therapy for Pulmonary Mycobacterium Avium Complex DiseaseCompletedNCT03672630Phase 2/3
• WGS of NTM From Sputum of NTM Lung Disease Patients and From Their EnvironmentsStatus unknownNCT03532438
• The Italian REgistry of Pulmonary Non-tuberculous mycobactEriaStatus unknownNCT03339063
• A Study of the Safety and Tolerability of Inhaled SNSP113 in Healthy Subjects and Subjects With Stable Cystic FibrosisTerminatedNCT03309358Phase 1
• Inhaled Nitric Oxide for Patients With MABSCCompletedNCT03208764Phase 2
• Liposomal Amikacin for Inhalation (LAI) in the Treatment of Mycobacterium Abscessus Lung DiseaseCompletedNCT03038178Phase 2
• Genome-Wide Association Study in Patients With Nontuberculous Mycobacterial Lung DiseaseCompletedNCT02832843
• A Prospective Registry For Non Tuberculous Mycobacterial (NTM) InfectionsStatus unknownNCT02355015
• Diagnostic Accuracy of Nontuberculous Mycobacterial Lung Disease Based on Chest CTCompletedNCT02340897
• Treatment Outcomes in Patient With Nontuberculous Mycobacterial DiseaseTerminatedNCT01680822
• Phase 1 Study of CEP-37250/KHK2804 in Subjects With Advanced Solid TumorsCompletedNCT01447732Phase 1
• Multicenter Study of Nontuberculous Mycobacteria in Cystic Fibrosis PatientsCompletedNCT00004296
• Placebo-Controlled Trial of Safety and Efficacy of Thalidomide in Patients With Infections Due to Mycobacterium and/or HIVCompletedNCT00002104Phase 1
• A Study to Evaluate the Safety and Efficacy of Azithromycin in Individual Patients With Serious Nontuberculous Mycobacterial Disease Who Are Failing or Intolerant of Other Available TherapyCompletedNCT00002085Not applicable
• Interleukin-12 in the Treatment of Severe Nontuberculous Mycobacterial InfectionsCompletedNCT00001911Phase 1
• Treatment of Non-Tuberculous Mycobacterial Infections With Interferon GammaCompletedNCT00001318Phase 2

← Mycobacterium Infections, Nontuberculous overview